Loading...
AFYA logo

Afya LimitedNasdaqGS:AFYA Aktierapport

Marknadsvärde US$1.3b
Aktiekurs
US$14.70
Ej tillgänglig
1Y-5.6%
7D1.0%
Portföljens värde
​
Utsikt

Afya Limited

NasdaqGS:AFYA Aktierapport

Börsvärde: US$1.3b

Afya (AFYA) Aktievy

Afya Limited är verksamt som en medicinsk utbildningsgrupp i Brasilien. Mer information

AFYA fundamental analys
Snöflinga Score
Värdering5/6
Framtida tillväxt1/6
Tidigare resultat5/6
Finansiell hälsa3/6
Utdelningar3/6

Belöningar

Handlar till 52.4% under vår uppskattning av dess verkliga värde

Intäkterna förväntas växa med 14.21% per år

Intäkterna ökade med 25.8% under det senaste året

Handlas till ett bra värde jämfört med konkurrenter och branschen

Riskanalys

Inga risker upptäckta för AFYA från våra riskkontroller.

AFYA Community Fair Values

Create Narrative

See what 31 others think this stock is worth. Follow their fair value or set your own to get alerts.

AFYA logo
Afya

AI Advances And Brazil Instability Will Shrink Traditional Demand

Key Takeaways Rapid growth of AI-powered and online education threatens Afya's traditional offerings, increasing competition and risking erosion of market share and pricing power. Macroeconomic instability, demographic shifts, and rising regulatory pressures in Brazil constrain enrollment growth and could compress margins and profitability.
View narrative
US$15.6
FV
5.8% undervärderad intrinsisk rabatt
6.19%
Revenue growth p.a.
13
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AFYA logo
Afya

Brazil Medical Education And Digital Trends Will Secure Future Opportunity

Key Takeaways Expanding medical education offerings and digital initiatives are strengthening revenue growth, operating leverage, and profitability through increased student intake and higher-margin recurring revenues. Operational efficiencies and disciplined acquisitions are enhancing margin expansion, earnings stability, and long-term market share in the Brazilian medical education sector.
View narrative
US$18.53
FV
20.7% undervärderad intrinsisk rabatt
5.54%
Revenue growth p.a.
73
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
AFYA logo
Afya

Telehealth And Brazil's Aging Population Will Transform Medical Education

Key Takeaways Afya is poised for sustained, above-consensus growth and margin expansion due to Brazil's physician shortage, demographic forces, and digital health penetration. Scalable operations, accretive acquisitions, and strong capital allocation establish Afya as a dominant consolidator and digital infrastructure leader in Brazilian healthcare education.
View narrative
US$25.62
FV
42.6% undervärderad intrinsisk rabatt
9.71%
Revenue growth p.a.
11
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AFYA logo
Afya

AFYA Market Outlook

Afya Limited (NASDAQ: AFYA) is a Brazilian company specializing in medical education and digital health services. Sector: Education Industry: Medical Education Market Capitalization: $1.4b (small cap) Major Competitors: Afya Limited (NASDAQ: AFYA) is a prominent player in Brazil's medical education sector.
View narrative
US$14.86
FV
1.1% undervärderad intrinsisk rabatt
9.72%
Revenue growth p.a.
59
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
View Stock Community

Afya Limited Konkurrenter

Prishistorik och prestanda

Sammanfattning av aktiekursernas upp- och nedgångar samt förändringar för Afya
Historiska aktiekurser
Aktuell aktiekursUS$14.70
52 veckors högstaUS$19.90
52 veckors lägstaUS$13.47
Beta0.52
1 månads förändring-0.61%
3 månaders förändring-6.31%
1 års förändring-5.59%
3 års förändring-4.36%
5 års förändring-41.46%
Förändring sedan börsintroduktionen-38.98%

Senaste nyheter och uppdateringar

Afya's 3Q25 And Investor Day Provide More Data On Undergraduate Competition Increasing

Dec 01

Recent updates

Afya's 3Q25 And Investor Day Provide More Data On Undergraduate Competition Increasing

Dec 01

Here's Why Afya (NASDAQ:AFYA) Can Manage Its Debt Responsibly

Sep 30
Here's Why Afya (NASDAQ:AFYA) Can Manage Its Debt Responsibly

Investors Will Want Afya's (NASDAQ:AFYA) Growth In ROCE To Persist

Sep 12
Investors Will Want Afya's (NASDAQ:AFYA) Growth In ROCE To Persist

Afya Limited's (NASDAQ:AFYA) Subdued P/E Might Signal An Opportunity

Jul 26
Afya Limited's (NASDAQ:AFYA) Subdued P/E Might Signal An Opportunity

Is Now The Time To Put Afya (NASDAQ:AFYA) On Your Watchlist?

Jun 15
Is Now The Time To Put Afya (NASDAQ:AFYA) On Your Watchlist?

Is Afya (NASDAQ:AFYA) A Risky Investment?

May 30
Is Afya (NASDAQ:AFYA) A Risky Investment?

Earnings Beat: Afya Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

May 11
Earnings Beat: Afya Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

The Return Trends At Afya (NASDAQ:AFYA) Look Promising

Apr 28
The Return Trends At Afya (NASDAQ:AFYA) Look Promising

We Think Afya (NASDAQ:AFYA) Can Stay On Top Of Its Debt

Feb 27
We Think Afya (NASDAQ:AFYA) Can Stay On Top Of Its Debt

AFYA Market Outlook

Laureate Education (NASDAQ: LAUR): An international network of campus-based and online universities, Laureate offers undergraduate and postgraduate degree programs globally, including in Latin America

Is There An Opportunity With Afya Limited's (NASDAQ:AFYA) 48% Undervaluation?

Jan 16
Is There An Opportunity With Afya Limited's (NASDAQ:AFYA) 48% Undervaluation?

Should You Be Adding Afya (NASDAQ:AFYA) To Your Watchlist Today?

Dec 13
Should You Be Adding Afya (NASDAQ:AFYA) To Your Watchlist Today?

Afya Continues To Be An Opportunity Even After Brazil's Depreciation

Nov 30
User avatar

Expanding Medical Practice Solutions And Tactical Acquisitions Fuel Robust Revenue Growth

Strategic acquisitions and expansion in medical practice solutions are expected to enhance revenue, profitability, and operational efficiency.

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Nov 17
Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Investors Holding Back On Afya Limited (NASDAQ:AFYA)

Nov 03
Investors Holding Back On Afya Limited (NASDAQ:AFYA)

Returns At Afya (NASDAQ:AFYA) Are On The Way Up

Oct 18
Returns At Afya (NASDAQ:AFYA) Are On The Way Up

Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply

Aug 29

Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors

Aug 29
Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors

Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Aug 15
Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Jul 17
Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jun 20
Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Afya's Results Are Improving And The Market Is Undervaluing It

Jun 06

Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

May 14
Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

AFYA: Mr Market Is Mistaken

Apr 29

Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Apr 27
Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Apr 09
Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Is Performing Well And Is A Buy

Mar 19

Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Mar 17
Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Feb 10
Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Jan 21
Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

Jan 03
Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Dec 07
These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

Nov 02
Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Sep 20
What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Aug 17
Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Afya GAAP EPS of R$1.12, revenue of R$598.16M; reaffirms FY22 guidance

Aug 23

White Brook Capital - AFYA Ltd: Cheap Stock, Good Business, Inherent Growth

Jul 28

Afya: Margin And Organic Growth Struggles Remain Top Of Mind

Apr 14

Afya On A Grey Price Area

Dec 25

Aktieägarnas avkastning

AFYAUS Consumer ServicesUS Marknad
7D1.0%-0.05%2.6%
1Y-5.6%-11.0%14.2%

Avkastning vs industri: AFYA översteg US Consumer Services branschen som gav -11 % under det senaste året.

Avkastning vs Marknaden: AFYA presterade sämre än US marknaden som gav 14.2 % under det senaste året.

Prisvolatilitet

Is AFYA's price volatile compared to industry and market?
AFYA volatility
AFYA Average Weekly Movement3.1%
Consumer Services Industry Average Movement8.6%
Market Average Movement6.5%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stabil aktiekurs: AFYA har inte haft någon betydande prisvolatilitet under de senaste 3 månaderna jämfört med marknaden för US.

Volatilitet över tid: AFYA s veckovolatilitet ( 3% ) har varit stabil under det senaste året.

Om företaget

GrundadAnställdaVD OCH KONCERNCHEFWebbplats
1999n/aVirgilio Deloy Gibbonwww.afya.com.br

Afya Limited är verksamt som en medicinsk utbildningsgrupp i Brasilien. Bolaget är verksamt inom tre segment: Undergrad, Continuing Education och Digital Services. Bolaget erbjuder utbildningsprodukter och -tjänster, inklusive läkarskolor, förberedande kurser för läkarutbildning, kurser för doktorander och andra program till livslånga medicinska elever som är inskrivna i bolagets distributionsnätverk, samt till tredjepartsläkarskolor.

Afya Limited Sammanfattning av grunderna

Hur förhåller sig Afya:s resultat och omsättning till dess börsvärde?
AFYA grundläggande statistik
BörsvärdeUS$1.33b
Vinst(TTM)US$131.94m
Intäkter(TTM)US$657.19m
10.1x
P/E-förhållande
2.0x
P/S-förhållande

Är AFYA övervärderat?

Se Verkligt värde och värderingsanalys

Resultat & intäkter

Viktig lönsamhetsstatistik från den senaste resultatrapporten (TTM)
AFYA resultaträkning (TTM)
IntäkterR$3.63b
Kostnad för intäkterR$1.27b
BruttovinstR$2.36b
Övriga kostnaderR$1.63b
IntäkterR$729.43m

Senast redovisade vinst

Sep 30, 2025

Nästa vinstdatum

n/a

Vinst per aktie (EPS)8.04
Bruttomarginal64.98%
Nettovinstmarginal20.08%
Skuld/egenkapitalförhållande40.0%

Hur har AFYA utvecklats på lång sikt?

Se historisk utveckling och jämförelse

Utdelningar

1.5%
Aktuell utdelningsavkastning
17%
Utbetalningskvot

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2025/12/24 11:41
Aktiekurs vid dagens slut2025/12/23 00:00
Intäkter2025/09/30
Årlig intjäning2024/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om den analysmodell som används för att generera denna rapport finns på vår Github-sida, vi har också guider om hur man använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Afya Limited bevakas av 14 analytiker. 8 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Flavio YoshidaBofA Global Research
Valeria PariniBradesco S.A. Corretora de Títulos e Valores Mobiliários
Marcio OsakoBradesco S.A. Corretora de Títulos e Valores Mobiliários